Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Geron Corp.

Start price
Target price
Perf. (%)
€1.68
12.03.24
-
12.03.25
81.49%
15.03.24

Could be very worthwhile Investment >20% year
Global_Player 
12.03.24 50%
sell
Regulus Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.22
12.03.24
-
12.03.25
-9.01%
16.03.24

Probably not worthwhile Investment
daimler1 
12.03.24 50%
buy
Amazon.com Inc.

Start price
Target price
Perf. (%)
€159.98
10.03.24
€165.00
10.03.25
4.05%
28.03.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
Traumtanz 
10.03.24 50%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€64.50
08.03.24
-
08.03.25
-8.53%
15.03.24

Could be worthwhile Investment >10% per year
Global_Player 
08.03.24 50%
buy
Microstrateg.a New

Start price
Target price
Perf. (%)
€1,181.0
08.03.24
-
08.04.24
18.37%
09.04.24

Could be worthwhile Investment >10% per year
melinda 
08.03.24 20%
buy
Albemarle Corp

Start price
Target price
Perf. (%)
€102.40
05.03.24
-
05.03.25
16.45%
03.04.24

Growths faster than the competition
fenjal 
05.03.24 50%
buy
Netflix Inc.

Start price
Target price
Perf. (%)
€565.10
05.03.24
€570.00
05.03.25
4.58%
12.04.24

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Traumtanz 
05.03.24 50%
sell
Super Micro Computer

Start price
Target price
Perf. (%)
€1,044.5
04.03.24
-
04.03.25
-3.73%
16.03.24

Capable Management
Probably not worthwhile Investment
Few uniques
me8 
04.03.24 0%
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€25.60
04.03.24
-
04.03.25
-0.78%
15.03.24

Risky Investment
michaelkr 
04.03.24 50%
sell
Vanda Pharmaceuticals

Start price
Target price
Perf. (%)
€4.00
04.03.24
-
04.03.25
-13.00%
16.03.24

Probably not worthwhile Investment
daimler1 
04.03.24 50%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€83.00
03.03.24
€180.00
31.05.26
-16.27%
29.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
03.03.24 70%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.96
03.03.24
-
03.03.25
10.06%
15.03.24

Could be very worthwhile Investment >20% year
bundfuture 
03.03.24 50%
sell
Apple Inc.

Start price
Target price
Perf. (%)
€164.60
02.03.24
-
02.03.25
-2.65%
28.03.24

Subdi 
02.03.24 10%
buy
Microstrateg.a New

Start price
Target price
Perf. (%)
€1,039.5
02.03.24
€1,200.0
02.03.25
57.29%
16.03.24

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High valuation
Risky balance sheet
skatcup 
02.03.24 80%
buy
Appian

Start price
Target price
Perf. (%)
€33.32
02.03.24
€45.00
02.03.25
-0.09%
16.03.24

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
skatcup 
02.03.24 80%
buy
Dell Technologies Inc

Start price
Target price
Perf. (%)
€113.40
01.03.24
-
01.03.25
0.18%
01.03.24

Could be worthwhile Investment >10% per year
Vassago1 
01.03.24 50%
buy
Micron Technology Inc.

Start price
Target price
Perf. (%)
€85.00
01.03.24
€86.00
01.03.25
3.76%
02.03.24

positive Cash Flow expected
Revenue growth >5% per year expected
High dividend yield expected
Valuable balance sheet
Traumtanz 
01.03.24 50%
buy
Micron Technology Inc.

Start price
Target price
Perf. (%)
€82.14
29.02.24
€83.00
28.02.25
3.48%
01.03.24

positive Cash Flow expected
Revenue growth >5% per year expected
High dividend yield expected
Valuable balance sheet
Traumtanz 
29.02.24 50%
buy
Salesforce.com

Start price
Target price
Perf. (%)
€278.00
27.02.24
€281.00
27.02.25
5.11%
02.03.24

Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
Future proof or reliable business model
Traumtanz 
27.02.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.71
24.02.24
-
24.02.25
-5.26%
02.03.24

Could be worthwhile Investment >10% per year
Global_Player 
24.02.24 50%
buy
Super Micro Computer

Start price
Target price
Perf. (%)
€779.80
22.02.24
€1,000.00
22.02.25
19.42%
02.03.24

Known brand
Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Low dividend yield expected
skatcup 
22.02.24 90%
buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€695.90
22.02.24
€1,400.0
22.02.25
10.65%
02.03.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
High Investments for future growth
skatcup 
22.02.24 100%
sell
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.55
22.02.24
-
22.02.25
4.52%
02.03.24

Very low/no dividend yield expected
Risky Investment
EBIT decline/stagnation expected
High valuation
kostojunior 
22.02.24 0%
sell
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.19
22.02.24
-
22.02.25
-10.80%
02.03.24

Nicheplayer
Risky Investment
kostojunior 
22.02.24 0%
sell
NVIDIA Corp.

Start price
Target price
Perf. (%)
€695.90
22.02.24
€444.00
22.02.25
10.65%
02.03.24

Future proof or reliable business model
Sustainability is not important
High risks for its business
Lower EBIT Margin than peer group
kostojunior 
22.02.24 0%